Op0205 Phase I Study of D-0120, a Novel Urat1 Inhibitor in Clinical Development for Hyperuricemia and Gout
Year: 2020
Type: article
Study design: Clinical Trial
Source: Annals of the Rheumatic Diseases
Authors: L. Zhang, D. Wyatt, K. Stazzone, Z. Shi, Y. Wang
Institutions: InventisBio Co., Ltd. (China), Syneos Health (United States)
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3045697709